California, Colorado, Illinois, and Minnesota filed a lawsuit against the Trump administration for rescinding over $600 ...

The FDA issued a refuse-to-file letter for Moderna’s mRNA-based flu vaccine amid a shift toward stricter scrutiny of mRNA ...

Patients in the pediatric intensive care unit who received high-risk rounds were less likely to incur a hospital-acquired condition.

Increased numbers of state-level abortion restrictions were associated with measurable rises in maternal mortality.

Real-world study results showed that sonidegib was associated with greater treatment persistence than vismodegib at 12 months among adults with BCC.

Reinstatement of Medicare's 3-day hospitalization requirement increased inpatient stays, without reducing SNF utilization.

Higher ultraprocessed food consumption was linked to higher rates of mortality after cancer diagnosis despite diet quality.

Phase 3 trial results show combined ixekizumab and tirzepatide therapy outperforms ixekizumab alone for patients with psoriasis and obesity or overweight.

President Donald Trump rescinded the EPA's endangerment finding, which allowed for federal regulations on pollution to protect public health.

Remibrutinib shows significant complete response rates across 3 chronic inducible urticaria subtypes in the phase 3 RemIND trial.

Increasing applications of HCCP among patients with postherpetic neuralgia were associated with increasing improvements in outcomes at 12 months.

Several factors have been identified that may predict super response or refractory response to rituximab among patients with pemphigus.